Free Trial
NYSE:FNA

Paragon 28 (FNA) Stock Price, News & Analysis

Paragon 28 logo
$7.15 +0.07 (+0.99%)
(As of 11/8/2024 ET)

About Paragon 28 Stock (NYSE:FNA)

Key Stats

Today's Range
$7.00
$7.33
50-Day Range
$4.77
$8.32
52-Week Range
$4.65
$14.79
Volume
605,438 shs
Average Volume
549,143 shs
Market Capitalization
$597.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.25
Consensus Rating
Buy

Company Overview

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.

Paragon 28 Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
46th Percentile Overall Score

FNA MarketRank™: 

Paragon 28 scored higher than 46% of companies evaluated by MarketBeat, and ranked 678th out of 969 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Paragon 28 has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Paragon 28 has received no research coverage in the past 90 days.

  • Read more about Paragon 28's stock forecast and price target.
  • Earnings Growth

    Earnings for Paragon 28 are expected to grow in the coming year, from ($0.68) to ($0.54) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Paragon 28 is -10.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Paragon 28 is -10.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Paragon 28 has a P/B Ratio of 3.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Paragon 28's valuation and earnings.
  • Percentage of Shares Shorted

    17.57% of the float of Paragon 28 has been sold short.
  • Short Interest Ratio / Days to Cover

    Paragon 28 has a short interest ratio ("days to cover") of 12.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Paragon 28 has recently decreased by 2.71%, indicating that investor sentiment is improving.
  • Dividend Yield

    Paragon 28 does not currently pay a dividend.

  • Dividend Growth

    Paragon 28 does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    17.57% of the float of Paragon 28 has been sold short.
  • Short Interest Ratio / Days to Cover

    Paragon 28 has a short interest ratio ("days to cover") of 12.7, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Paragon 28 has recently decreased by 2.71%, indicating that investor sentiment is improving.
  • News Sentiment

    Paragon 28 has a news sentiment score of 0.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.37 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 23 news articles for Paragon 28 this week, compared to 6 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Paragon 28 insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    15.32% of the stock of Paragon 28 is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    63.57% of the stock of Paragon 28 is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Paragon 28's insider trading history.
Receive FNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Paragon 28 and its competitors with MarketBeat's FREE daily newsletter.

FNA Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines

FNA Stock Analysis - Frequently Asked Questions

Paragon 28's stock was trading at $12.43 at the beginning of 2024. Since then, FNA stock has decreased by 42.5% and is now trading at $7.15.
View the best growth stocks for 2024 here
.

Paragon 28, Inc. (NYSE:FNA) issued its quarterly earnings data on Thursday, August, 8th. The company reported ($0.17) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.17). Paragon 28's revenue for the quarter was up 19.6% compared to the same quarter last year.

Paragon 28 (FNA) raised $125 million in an IPO on Friday, October 15th 2021. The company issued 7,800,000 shares at $15.00-$17.00 per share. BofA Securities and Piper Sandler acted as the underwriters for the IPO and Canaccord Genuity, JMP Securities and Needham & Company were co-managers.

Paragon 28's top institutional shareholders include Thrivent Financial for Lutherans (0.81%), Park Edge Advisors LLC (0.72%), Inspire Investing LLC (0.07%) and GSA Capital Partners LLP (0.07%). Insiders that own company stock include Mvm Partners Llp, B Ag Bird, Albert Dacosta, Frank S Bono, Matthew Jarboe, Lee Rosenthal, Thomas P Schnettler and Kristina Wright.
View institutional ownership trends
.

Shares of FNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Paragon 28 investors own include Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
8/08/2024
Today
11/10/2024
Next Earnings (Confirmed)
11/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Fax
N/A
Employees
343,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$15.25
High Stock Price Target
$20.00
Low Stock Price Target
$11.00
Potential Upside/Downside
+113.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-57,530,000.00
Pretax Margin
-27.29%

Debt

Sales & Book Value

Annual Sales
$216.39 million
Book Value
$2.05 per share

Miscellaneous

Free Float
70,743,000
Market Cap
$597.31 million
Optionable
Optionable
Beta
1.01
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSE:FNA) was last updated on 11/10/2024 by MarketBeat.com Staff
From Our Partners